Brian D. Lehmann, Ph.D.
Affiliations: | 2007 | East Carolina University, Greenville, NC, United States |
Area:
RadiologyGoogle:
"Brian Lehmann"Parents
Sign in to add mentor| David M. Terrian | grad student | 2007 | East Carolina University | |
| (Determinants of radiosensitivity in human prostate cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lehmann BD, Colaprico A, Silva TC, et al. (2021) Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes. Nature Communications. 12: 6276 |
| Korolkova OY, Widatalla SE, Whalen DS, et al. (2020) Reciprocal expression of Annexin A6 and RasGRF2 discriminates rapidly growing from invasive triple negative breast cancer subsets. Plos One. 15: e0231711 |
| Schafer JM, Lehmann BD, Gonzalez-Ericsson PI, et al. (2020) Targeting MYCN-expressing triple-negative breast cancer with BET and MEK inhibitors. Science Translational Medicine. 12 |
| Lander EM, Lehmann BD, Shah PD, et al. (2020) A phase II trial of atezolizumab (anti-PD-L1) with carboplatin in patients with metastatic triple-negative breast cancer (mTNBC). Journal of Clinical Oncology. 38: TPS1112-TPS1112 |
| Lehmann BD, Abramson VG, Sanders M, et al. (2019) TBCRC 032 IB/II Multicenter Study: Molecular insights to AR antagonist and PI3K inhibitor efficacy in patients with AR+ metastatic triple-negative breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Lehmann BD, Shaver TM, Johnson DB, et al. (2019) Identification of targetable recurrent MAP3K8 rearrangements in melanomas lacking known driver mutations. Molecular Cancer Research : McR |
| Whalen DS, Widatalla SE, Korolkova OY, et al. (2019) Implication of calcium activated RasGRF2 in Annexin A6-mediated breast tumor cell growth and motility. Oncotarget. 10: 133-151 |
| Gonzalez-Ericsson P, Lehmann B, Mobley B, et al. (2019) Abstract P2-06-09: Identification of oncogenic gene fusions in triple-negative breast cancer metastatic to the brain Cancer Research. 79 |
| Lehmann BD, Colaprico A, Chen J, et al. (2019) Abstract LB-301: Integrative genomic analysis identifies distinct mutational, epigenetic and immunological patterns among triple-negative breast cancer subtypes Cancer Research. 79 |
| Rida P, Ogden A, Ellis IO, et al. (2018) First international TNBC conference meeting report. Breast Cancer Research and Treatment |